Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
Jonathan K. M. Lim, Alberto Delaidelli, Sean W. Minaker, Haifeng Zhang, Milena Čolović, Hua Yang, Gian Luca Negri, Silvia von Karstedt 等 12 位
BC Cancer Agency University of British Columbia TRIUMF University of Cologne
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Significance RAS genes are among the most mutated proto-oncogenes in human cancer. The mechanisms supporting RAS transformation are not fully understood, particularly regarding the relative contributions of oxidant versus antioxidant pathways. Here, we report that the cystine/glutamate transporter xCT is essential for RAS-induced tumorigenicity by enhancing antioxidant glutathione synthesis. Our findings uncover that RAS controls xCT transcription by downstream activation of ETS-1 to synergize with ATF4. This has clinical relevance since xCT expression is upregulated in human cancers exhibiting an activated RAS pathway. Therefore, oncogenic RAS transformation is supported by induction of an antioxidant program, highlighting xCT as a potential vulnerability for therapeutic targeting.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Sulfur Compounds in Biology
Redox biology and oxidative stress · Amino Acid Enzymes and Metabolism